Comparative Pharmacology
Head-to-head clinical analysis: ECONOCHLOR versus POLYTRIM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ECONOCHLOR versus POLYTRIM.
ECONOCHLOR vs POLYTRIM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Econazole nitrate inhibits fungal cytochrome P450 14α-demethylase, blocking ergosterol synthesis, disrupting fungal cell membrane integrity and function.
Polymyxin B sulfate binds to the lipopolysaccharide (LPS) in the outer membrane of Gram-negative bacteria, disrupting membrane integrity and causing cell death. Trimethoprim inhibits bacterial dihydrofolate reductase, blocking the conversion of dihydrofolic acid to tetrahydrofolic acid, thereby inhibiting bacterial DNA synthesis.
0.12 mg/kg IV bolus over 30 seconds, followed by continuous IV infusion at 0.12-0.6 mg/kg/h.
1 drop in the affected eye(s) every 4 hours for 7-10 days.
None Documented
None Documented
Terminal half-life: 8-10 hours in adults with normal renal function; prolonged to 15-20 hours in renal impairment (CrCl <30 mL/min).
Terminal elimination half-life of polymyxin B is 4.5-6 hours; for trimethoprim it is 8-10 hours. In renal impairment, half-life of both components is prolonged.
Renal: 80-90% as unchanged drug; fecal: <1%; biliary: minimal.
Renal excretion accounts for approximately 40% of the dose as unchanged polymyxin B and 60% as unchanged trimethoprim. Biliary/fecal elimination is minimal (<5% for each component).
Category C
Category C
Ophthalmic Antibiotic
Ophthalmic Antibiotic